← Open Payments lookup

MEGAN SCOTT: Open Payments

NPI 1033453634 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$235 in 9 payments from 6 companies in 2025. Trend: 2023 $195 · 2024 $23 · 2025 $235

Food & beverage: $235
CompanyPaymentsAmount
Novo Nordisk Inc3$59
Janssen Biotech, Inc.2$50
Organogenesis Inc.1$41
Astellas Pharma US Inc1$37
BeiGene USA, Inc.1$28
Smith+Nephew, Inc.1$20

Products named: Ozempic, APLIGRAF, Veozah, RYBREVANT, TEVIMBRA, ERLEADA, RENASYS TOUCH.

Industry payments across NY — which companies pay providers there.